Peer Review History

Original SubmissionApril 25, 2024
Decision Letter - Mukhtiar Baig, Editor

PONE-D-24-13204Exploring Medical Error Taxonomies and Human Factors in Simulation-based Healthcare EducationPLOS ONE

Dear Dr. Schwarz,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Aug 29 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Mukhtiar Baig, Ph.D.

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at 

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. We note that the grant information you provided in the ‘Funding Information’ and ‘Financial Disclosure’ sections do not match. 

When you resubmit, please ensure that you provide the correct grant numbers for the awards you received for your study in the ‘Funding Information’ section.

3. Thank you for stating the following in the Acknowledgments Section of your manuscript: 

"This research was partially supported by the Specific University Research grant provided to  Masaryk University by the Ministry of Education of the Czech Republic (MUNI/A/1595/2023, MUNI/A/1551/2023) and also in part supported by the Ministry of Health of the Czech Republic (FNBr, 65269705). We thank Mr. Radomír Beneš and the American Manuscript Editors for the English language editing that greatly improved the quality of this manuscript."

We note that you have provided funding information that is not currently declared in your Funding Statement. However, funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form. 

Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows: 

"This research was partially supported by the Specific University Research grant provided to Masaryk University by the Ministry of Education of the Czech Republic (MUNI/A/1595/2023, MUNI/A/1551/2023) and also in part supported by the Ministry of Health of the Czech Republic (FNBr, 65269705)."

Please include your amended statements within your cover letter; we will change the online submission form on your behalf.

4. Thank you for stating the following financial disclosure: 

"This research was partially supported by the Specific University Research grant provided to Masaryk University by the Ministry of Education of the Czech Republic (MUNI/A/1595/2023, MUNI/A/1551/2023) and also in part supported by the Ministry of Health of the Czech Republic (FNBr, 65269705)."

Please state what role the funders took in the study.  If the funders had no role, please state: ""The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."" 

If this statement is not correct you must amend it as needed. 

Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf.

5. Thank you for stating in your Funding Statement: 

"This research was partially supported by the Specific University Research grant provided to Masaryk University by the Ministry of Education of the Czech Republic (MUNI/A/1595/2023, MUNI/A/1551/2023) and also in part supported by the Ministry of Health of the Czech Republic (FNBr, 65269705)."

Please provide an amended statement that declares *all* the funding or sources of support (whether external or internal to your organization) received during this study, as detailed online in our guide for authors at http://journals.plos.org/plosone/s/submit-now.  Please also include the statement “There was no additional external funding received for this study.” in your updated Funding Statement. 

Please include your amended Funding Statement within your cover letter. We will change the online submission form on your behalf.

6. When completing the data availability statement of the submission form, you indicated that you will make your data available on acceptance. We strongly recommend all authors decide on a data sharing plan before acceptance, as the process can be lengthy and hold up publication timelines. Please note that, though access restrictions are acceptable now, your entire data will need to be made freely accessible if your manuscript is accepted for publication. This policy applies to all data except where public deposition would breach compliance with the protocol approved by your research ethics board. If you are unable to adhere to our open data policy, please kindly revise your statement to explain your reasoning and we will seek the editor's input on an exemption. Please be assured that, once you have provided your new statement, the assessment of your exemption will not hold up the peer review process.

7. Please include your full ethics statement in the ‘Methods’ section of your manuscript file. In your statement, please include the full name of the IRB or ethics committee who approved or waived your study, as well as whether or not you obtained informed written or verbal consent. If consent was waived for your study, please include this information in your statement as well.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Partly

Reviewer #2: Partly

Reviewer #3: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: No

Reviewer #2: Yes

Reviewer #3: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: No

Reviewer #2: No

Reviewer #3: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: i. Literature review is shallow

ii. Future scope is missing

iii. All abbreviations should only be used after their first definition

iv. Section should present the methodology algorithmically

iv. Novelty of the proposed work should be established by comparing the same with comparable work.

v. Sections break directly into sub-sections breaking the continuity of the manuscript.

vi. Sound literature review in tabulated form would be desirable to perform meta-analysis of available work and establish.

vii. There are areas that require further practical discussion and better linking of the results discussion together. The research methodology is weak. Why did you choose this methodology? The technical and practical discussion, as well as the comparison with recent previous work on this topic, should be thoroughly considered.

viii. The quality of the paper is weak in the technical discussion, and the explanatory results have been discussed before. Also, some parts in the comparison of figures don’t make sense. The results are not sufficient, and the conclusion is weak. The references are not sufficient and need a comprehensive update, as well as an update to the sources list until 2024. Major revisions are recommended so that the authors address all of this through examination and validation adequately to meet the standards and strength of the journal. The technical and practical discussion, as well as the comparison with recent previous work on this topic, should be thoroughly considered.

ix. Most sections have written with an AI tools and this missed sense in the information and understanding.

x. Both the discussion and practical application and the technical sense are missing. There is no discussion that conveys a true understanding.

xi. The introduction may provide a solid background on the importance of addressing medical errors and patient safety.

xii. Consider expanding on why existing taxonomies are inadequate for simulation-based settings upfront to justify the need for your proposed approach.

xiii. It is clearly stated that a p-value of under 0.1 and a correlation coefficient (tau) absolute value exceeding 0.1 were used as thresholds. However, the rationale behind choosing these thresholds could be elaborated. Provide a brief explanation for selecting these specific p-value and correlation coefficient thresholds. Example: “A p-value threshold of 0.1 was chosen to capture marginally significant associations, while a tau value exceeding 0.1 was used to identify moderately strong relationships.

xiv. Challenges related to error reporting are well-articulated. However, it would be beneficial to propose some strategies for overcoming these barriers.

xv. Suggest methods for mitigating gaps in literature review and enhancing future taxonomy validation. Example: “Future research should include a systematic review of less widely known taxonomies and consider the application of natural language processing to identify relevant literature.”

xvi. The manuscript discusses classifications and their relationships, but there is insufficient analysis on the accuracy and reliability of these classifications. The methodology for evaluating the accuracy of the proposed or merged classifications isn’t explicitly detailed.

xvii. The accuracy of the proposed classifications needs to be rigorously analyzed. Include metrics such as precision, recall, and F1 score to evaluate the performance of the classifications. Benchmark these against existing classifications to demonstrate their relative effectiveness.

xviii. The technical discussion is not currently high-level and lacks depth. Provide detailed descriptions of the methodologies and tools used to develop and implement the classification system in the simulation environment. Include discussions of any technical challenges encountered and how they were addressed.

xix. The proposed classification system needs stronger validation. Conduct validation studies in real-world simulation settings and present detailed results and analysis to support the efficacy of the modified taxonomy. Discuss how the findings from these validation studies enhance the credibility of your proposed approach.

xx. Sections of the manuscript involving AI are not well integrated and lack relevance. Clearly explain how AI technologies were utilized in the study, specifying the AI methods used and their role in the classification process. Highlight the impact of AI on the accuracy, efficiency, or reliability of the classification system with specific examples.

xxi. The paper needs proofreading to correct any typographical, grammatical, or structural errors. Ensure that terms and abbreviations are defined upon first use and employed consistently throughout the manuscript. Address any incomplete or unclear phrases, such as “human limitatUnderstanding.

xxii. Eaborate on how the study’s findings will be practically applied in simulation training. Provide specific examples of scenarios or training modules where the insights will be implemented. Detail how “red flags” will be incorporated into debriefing sessions.

Reviewer #2: Please include tables and charts for quantitative data collected through questionnaire. Please clarify how the study could be replicated in both national and international context. Also incorporate the suggested changes in the research manuscript, highlighted with comments attached in comment box.

Please refer to the reviewed manuscript for reference.

Reviewer #3: The methodology of the manuscript is robust, comprehensive and well-structured and thorough to identify critical gaps in literature. The topic is extremely crucial to the progress of medical education.

However, Methodology can be improved by clearly stating the study design of this manuscript in the beginning of the section. As in first glance it appears to be a review.

It would be good to clarify the various taxonomies and their usage in both types of medical errors with clarity instead of just a table.

The number of participants should be stated in methodology section instead of statistical analysis.

The level of the learner should be clearly specified. Is the study conducted on undergraduates, interns or residents?

Discussion should be more detailed and comprehensive, comparing the study results with previous studies.

A lot of material elaborated in the limitation's sections can be a part of discussion

Last paragraph of limitations is way forward, it should be separated from limitations

Literature is comprehensive and thoroughly cited, however the manuscript can be improved by citing latest research.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Ebrahim E. Elsayed

Reviewer #2: No

Reviewer #3: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Attachments
Attachment
Submitted filename: PONE-D-24-13204.pdf
Revision 1

We have provided a rebuttal letter with detailed responses to all reviewers' comments.

Attachments
Attachment
Submitted filename: ExpMedErr-Responses to comments of reviewers.pdf
Decision Letter - Mukhtiar Baig, Editor

Exploring Medical Error Taxonomies and Human Factors in Simulation-based Healthcare Education

PONE-D-24-13204R1

Dear Dr. Schwarz,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Mukhtiar Baig, Ph.D.

Academic Editor

PLOS ONE

Formally Accepted
Acceptance Letter - Mukhtiar Baig, Editor

PONE-D-24-13204R1

PLOS ONE

Dear Dr. Schwarz,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

If revisions are needed, the production department will contact you directly to resolve them. If no revisions are needed, you will receive an email when the publication date has been set. At this time, we do not offer pre-publication proofs to authors during production of the accepted work. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few weeks to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Professor Mukhtiar Baig

Academic Editor

PLOS ONE

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .